State Street Corp Palatin Technologies Inc Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.37 - $0.54 $21,252 - $31,017	57,440 Added 8.21%	757,455 $349,000
Q2 2021 Aug 16, 2021	BUY	$0.48 - $0.72 $302,492 - $453,738	630,193 Added 902.57%	700,015 $427,000
Q2 2020 Aug 14, 2020	SELL	$0.41 - $0.73 $1.48 Million - $2.64 Million	-3,618,837 Reduced 98.11%	69,822 $36,000
Q1 2020 May 11, 2020	BUY	$0.36 - $0.79 $1.33 Million - $2.91 Million	3,688,659 New	3,688,659 $1.56 Million

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.76M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.